Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
DYN
DYN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
DYN News
FCPM III Services B.V. Reduces Stake in Dyne Therapeutics
1d ago
Fool
FCPM III Reduces Stake in Dyne Therapeutics by $14 Million
1d ago
Yahoo Finance
Dyne Therapeutics Submits BLA for DMD Treatment Z-rostudirsen
4d ago
NASDAQ.COM
Dyne Therapeutics Submits BLA for Accelerated Approval of z-rostudirsen
5d ago
Newsfilter
Dyne Therapeutics Grants Inducement Equity Awards to New Employees
May 20 2026
Newsfilter
Dyne Therapeutics Initiates Late-Stage DMD Trial for z-rostudirsen
May 20 2026
stocktwits
Dyne Therapeutics Launches Late-Stage Trial for DMD Therapy
May 20 2026
seekingalpha
Saturn V Capital Management Sells Dyne Therapeutics Shares
May 19 2026
Fool
Saturn V Sells Dyne Therapeutics Shares Worth $14.17 Million
May 19 2026
NASDAQ.COM
Dyne Therapeutics Reports Positive FDA Meeting Progress
May 11 2026
Newsfilter
Dyne Therapeutics Presents New Data on FORCE Platform's CNS Delivery
Apr 27 2026
Newsfilter
Dyne Therapeutics Presents Clinical Trial Posters on DMD and DM1 at AMCP 2026
Apr 01 2026
Newsfilter
Dyne Therapeutics Shares Surge 11.81% on Buy Rating
Mar 11 2026
Yahoo Finance
U.S. Stocks Rise as NIO Reports Strong Earnings
Mar 10 2026
Benzinga
Relmada Therapeutics Shares Surge 40.8% on Promising Trial Data
Mar 09 2026
Benzinga
Dyne Therapeutics Announces Major Clinical Updates on DMD and DM1 Trials
Mar 09 2026
NASDAQ.COM
Show More News
